PKCδ Peptide Substrate acetate
Based on 1 Customer Validation
PKCδ Peptide Substrate acetate is a highly selective peptide substrate targeting PKCδ. PKCδ Peptide Substrate acetate can only be efficiently catalyzed for phosphorylation modification by PKCδ, and Thr431 is the sole phosphorylation site. PKCδ Peptide Substrate acetate binds to the catalytic pocket of PKC in a competitive manner, but exhibits no PKC agonistic or inhibitory activity. PKCδ Peptide Substrate acetate is a dedicated biochemical probe for the quantitative detection of PKCδ in vitro, and can be used for studies on PKCδ-related pathways.
For research use only. We do not sell to patients.
- Purity : 98.30%
- Formula: C109H191N35O29S·xC2H4O2
- Molecular Weight:2487.96 (free base)
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Biological Activity
Description
In Vitro
PKCδ Peptide Substrate acetate acts as a selective, high-affinity substrate for recombinant human PKCδ (expressed in Sf9 cells) with a Km of 0.98 μM, and is a poorer substrate for other recombinant human PKC isozymes including PKCα, PKCβI, and PKCζ[2].
The PKCδ Peptide Substrate acetate is an absolutely specific substrate for PKCδ, exhibiting efficient phosphorylation by PKCδ with a Km of 22.9 μM, while showing no significant phosphorylation by cPKC, PKCβ, PKCγ, PKCε, PKCη, or PKCζ, and only minimal phosphorylation by PKCα[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Molecular Weight 2487.96 (free base)
-
Formula C109H191N35O29S·xC2H4O2
-
Color White to off-white
-
SMILES
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(O)=O)C(N[C@@H](CCSC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N.CC(O)=O.[x]
-
Sequence
Arg-Phe-Ala-Val-Arg-Asp-Met-Arg-Gln-Thr-Val-Ala-Val-Gly-Val-Ile-Lys-Ala-Val-Asp-Lys-Lys
-
Sequence Shortening
RFAVRDMRQTVAVGVIKAVDKK
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
H2O : 5 mg/mL (Need ultrasonic)
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kang JH. Protein Kinase C (PKC) Isozymes and Cancer. New Journal of Science. 2014;2014(1):231418.
[2]. Nishikawa K, Toker A, Johannes FJ, et al.. Determination of the specific substrate sequence motifs of protein kinase C isozymes. The Journal of biological chemistry. 1997 Jan 10;272(2):952-60. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)